Biopharma, healthcare stocks set for Q3 bounce

Shares in companies in the supply chain of biopharma and healthcare services surged in Shanghai and Shenzhen last week.

The biggest gain was made by Er-Kang Pharmaceutical Ltd, which rose 10 percent. Analysts expect further rises in such stocks in the July-September quarter.

According to Shanghai-based Wind Information Co Ltd, a financial information provider, more than 180 companies listed in Shanghai and Shenzhen, out of the more than 220 that are focused on biopharma and healthcare sectors, gained last week. Their overall performance rose some 2 percent.